{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:10:38Z","timestamp":1790827838219,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.11.036","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T09:26:39Z","timestamp":1259400399000},"page":"1188-1192","source":"Crossref","is-referenced-by-count":9,"title":["Bordetella pertussis vaccine strains and circulating isolates in Serbia"],"prefix":"10.1016","volume":"28","author":[{"given":"Gordana","family":"Dakic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Kallonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Elomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Pljesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Vignjevic-Krastavcevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.11.036_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2217\/17460913.3.3.329","article-title":"Factors contributing to pertussis resurgence","volume":"June (3)","author":"He","year":"2008","journal-title":"Future Microbiol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.11.036_bib2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.inf.0000177282.53500.77","article-title":"Resurgence of pertussis in Europe","volume":"24","author":"Celentano","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.11.036_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJMp068288","article-title":"The control of pertussis\u20132007 and beyond","volume":"356","author":"Halperin","year":"2007","journal-title":"N Engl J Med"},{"issue":"May (Suppl.)","key":"10.1016\/j.vaccine.2009.11.036_bib4","article-title":"Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000","author":"McIntyre","year":"2002","journal-title":"Commun Dis Intell"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.036_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3201\/eid0703.010308","article-title":"Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?","volume":"Suppl. 7","author":"Mooi","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.11.036_bib6","unstructured":"WHO. World Health Organisation: immunization, vaccination and biologicals. Vaccine preventable diseases Vaccines monitoring system 2009 Global Summary Reference Time Series: SERBIA http:\/\/www.who.int\/immunization_monitoring\/en\/globalsummary\/timeseries\/tscoveragebycountry.cfm?C=SRB."},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.11.036_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s100960050455","article-title":"Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology","volume":"19","author":"Mooi","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.11.036_bib8","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/JCM.42.7.2890-2897.2004","article-title":"Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles","volume":"42","author":"Advani","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.11.036_bib9","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/JCM.43.8.3681-3687.2005","article-title":"Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years","volume":"43","author":"Elomaa","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.11.036_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1471-2180-8-162","article-title":"Bordetella pertussis isolates in Finland: serotype and fimbrial expression","volume":"8","author":"Heikkinen","year":"2008","journal-title":"BMC Microbiol"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2009.11.036_bib11","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/315881","article-title":"Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935\u20131999","volume":"182","author":"Cassiday","year":"2000","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.11.036_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1128\/IAI.66.2.670-675.1998","article-title":"Polymorphism in the Bordetella pertussis virulence factors P.69\/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution","volume":"66","author":"Mooi","year":"1998","journal-title":"Infect Immun"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.11.036_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1073\/pnas.88.2.345","article-title":"Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells","volume":"88","author":"Leininger","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.11.036_bib14","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1128\/JCM.39.12.4396-4403.2001","article-title":"Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years","volume":"39","author":"Weber","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2009.11.036_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1017\/S095026880300164X","article-title":"Temporal trends in circulating Bordetella pertussis strains in Australia","volume":"132","author":"Poynten","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.11.036_bib16","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/JCM.43.6.2856-2865.2005","article-title":"Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs","volume":"43","author":"Hallander","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"December (13)","key":"10.1016\/j.vaccine.2009.11.036_bib17","first-page":"R155","article-title":"Serotype specificity of vaccine-induced immunity to pertussis","volume":"2","author":"Preston","year":"1992","journal-title":"Commun Dis Rep CDR Rev"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.11.036_bib18","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1128\/JCM.00864-07","article-title":"Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis","volume":"45","author":"Hallander","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"November (Pt 11)","key":"10.1016\/j.vaccine.2009.11.036_bib19","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1099\/00221287-147-11-2885","article-title":"Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity","volume":"147","author":"King","year":"2001","journal-title":"Microbiology"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.11.036_bib20","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1128\/CVI.00177-07","article-title":"Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains","volume":"14","author":"Bottero","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"July (34)","key":"10.1016\/j.vaccine.2009.11.036_bib21","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.vaccine.2005.03.033","article-title":"Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine","volume":"23","author":"Pereira","year":"2005","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09018118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09018118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T23:16:50Z","timestamp":1590275810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09018118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09018118"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}